• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SOFRADIM PRODUCTION SAS MESH SOFRADIM - URETEX; MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC, FOR STRESS URINARY INCONTINENCE, RETR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SOFRADIM PRODUCTION SAS MESH SOFRADIM - URETEX; MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC, FOR STRESS URINARY INCONTINENCE, RETR Back to Search Results
Model Number URETEXSUP
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Calcium Deposits/Calcification (1758); Micturition Urgency (1871); Incontinence (1928); Unspecified Infection (1930); Pain (1994); Scar Tissue (2060); Scarring (2061); Urinary Tract Infection (2120); Discomfort (2330); Injury (2348); Hematuria (2558); Blood Loss (2597); No Code Available (3191); Constipation (3274)
Event Type  Injury  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment.It was reported that after implant, the patient experienced cystitis, pain with sexual activity, urinary tract infection, recurrent stress incontinence, vaginal discomfort, weak urine stream, sensation of incomplete emptying, heavy incontinence, vaginal tenderness, urethral hypomobility, failed kegel exercises/pelvic floor exercises, reduced bladder contractility, occasional urgency, micro-hematuria, nephrolithiasis, lithotripsy with stent placement, intermittent right flank pain, bleeding, calcification/left renal stone, persistent elevated creatinine level, vaginal scarring, bladder instability, mixed urinary incontinence, urgency of urination, dyspareunia, recurrent stress incontinence, and vaginal tenderness not just over sling area but also laterally and posteriorly, urethral hypomobility, and placement of gynecare tvt-o, drainage, mental and physical stress, vaginal vault damage, scar tissue, chronic constipation, irritable bowel syndrome, recurrent vaginal or bladder infections.The patient required a surgical and multiple non-surgical intervention.Complications post (uretex sup) implantation: on 2011: had recurring stress incontinence, pain with intercourse, weak urine stream, urinary tract infection (uti), sensation of incomplete emptying.On exam vaginal tenderness not just over sling area but also laterally and posteriorly.Urodynamics showed residual volume 100 cc prior to uds, 120 cc after uds, at 150 cc no sui, at 300 cc, stress incontinence with cough was + noted at 300 ml.Ordered for urine culture (b)(6) 2011: had stress urinary incontinence.Scheduled for placement of midurethral tvt-o gynecare tension-free taping for stress incontinence and cystoscopy.Additional mesh implant (using gynecare tvt-o) surgery: (b)(6) 2011: underwent placement of mid-urethral tvt-o gynecare tension-free taping for stress incontinence and cystoscopy for urethral hypermobility, stress urinary incontinence in a female under general anesthesia.On 2012: complications post additional mesh- implant and corresponding interventions: on exam noticed a tear along the edge of her right labia.Had intercourse and that hurts, probably from this tear.Urinalysis showed trace amount of blood.On 2013: had left sided flank pain.Assessed with 7 mm left renal stone on renal ultrasound.Scheduled for cystoscopy, left ureteroscopy, laser lithotripsy, stone extraction, retrograde pyelogram, ureteral stent placement.Additional surgery details: (b)(6) 2013: underwent cystoscopy, left ureteroscopy, laser lithotripsy, stone extraction, retrograde pyelogram, and ureteral stent placement for left renal stone under general anesthesia.On 2014: had microhematuria on urinalysis, intermittent bothersome right flank pain for the past month.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MESH SOFRADIM - URETEX
Type of Device
MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC, FOR STRESS URINARY INCONTINENCE, RETR
Manufacturer (Section D)
SOFRADIM PRODUCTION SAS
116 avenue du formans
trevoux 01600
FR  01600
Manufacturer (Section G)
SOFRADIM PRODUCTION SAS
116 avenue du formans
trevoux 01600
FR   01600
Manufacturer Contact
lisa hernandez
60 middletown ave
north haven, CT 06473
2034925563
MDR Report Key8696206
MDR Text Key147913924
Report Number9615742-2019-02184
Device Sequence Number1
Product Code OTN
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K012949
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 06/13/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/28/2011
Device Model NumberURETEXSUP
Device Catalogue NumberURETEXSUP
Device Lot NumberSGB00409
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 05/15/2019
Initial Date FDA Received06/13/2019
Date Device Manufactured02/01/2006
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age41 YR
Patient Weight64
-
-